Tafamidis Impurity 25 | CAS 67175-28-4 - Request Quote
Tafamidis Impurity 25
| SZ CAT No: | SZ-T076030 |
| CAS No | 67175-28-4 |
| Mol.F. | C7H4N2O7 |
| Mol.Wt. | 228.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tafamidis Impurity 25 is chemically 3-Hydroxy-2,6-dinitrobenzoic acid. Tafamidis Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Tafamidis Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tafamidis.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 67175-28-4
Purchase 67175-28-4
Order 67175-28-4
Enquire 67175-28-4
price of 67175-28-4
67175-28-4 Supplier
67175-28-4 Manufacturer
67175-28-4 Exporter
buy high quality Tafamidis Impurity 25
Purchase Tafamidis Impurity 25
Tafamidis Impurity 25 suppliers
Tafamidis Impurity 25 manufacturers
Tafamidis Impurity 25 price
Order Tafamidis Impurity 25
Enquire Tafamidis Impurity 25
Tafamidis Impurity 25 cost
Tafamidis Impurity 25 Supplier
Tafamidis Impurity 25 Distributor
Tafamidis Impurity 25 for Method Validation
Tafamidis Reference Standard
Tafamidis Impurity 25 for ANDA Filing
Tafamidis Impurity 25 for Forced Degradation Studies
Tafamidis Impurity 25 Identification Standards
Tafamidis Impurity 25 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


